Correction: Corrigendum: Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture

被引：0
|
作者：
Hiroki Ikeda
Ana Godinho-Santos
Sylvie Rato
Bénédicte Vanwalscappel
François Clavel
Kazuyuki Aihara
Shingo Iwami
Fabrizio Mammano
机构：
来源：
Scientific Reports | / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Type-I interferons (IFNs) induce the expression of hundreds of cellular genes, some of which have direct antiviral activities. Although IFNs restrict different steps of HIV replication cycle, their dominant antiviral effect remains unclear. We first quantified the inhibition of HIV replication by IFN in tissue culture, using viruses with different tropism and growth kinetics. By combining experimental and mathematical analyses, we determined quantitative estimates for key parameters of HIV replication and inhibition, and demonstrate that IFN mainly inhibits de novo infection (33% and 47% for a X4- and a R5-strain, respectively), rather than virus production (15% and 6% for the X4 and R5 strains, respectively). This finding is in agreement with patient-derived data analyses.
引用
收藏
相关论文
共 50 条
  • [31] ANTIBODY TO HIV-1 TAT PROTEIN INHIBITS THE REPLICATION OF VIRUS IN CULTURE
    STEINAA, L
    SORENSEN, AM
    NIELSEN, JO
    HANSEN, JES
    ARCHIVES OF VIROLOGY, 1994, 139 (3-4) : 263 - 271
  • [32] Cyclophilin A and HIV-1 replication
    Luban, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R758 - R758
  • [33] REGULATION OF REPLICATION OF HIV-1
    HASELTINE, WA
    CONTROL OF HUMAN RETROVIRUS GENE EXPRESSION, 1988, : 135 - 158
  • [34] HIV-1 replication cycle
    Ferguson, MR
    Rojo, DR
    von Lindern, JJ
    O'Brien, WA
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (03) : 611 - +
  • [35] Residual HIV-1 replication
    Pomerantz, RJ
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (01) : 13 - 15
  • [36] EFFECT OF AN ELEVATED-TEMPERATURE ON THE REPLICATION OF HIV-1 IN A MONOCYTIC CELL-LINE
    SCHWEITZERTHUMANN, C
    KIRN, A
    AUBERTIN, AM
    RESEARCH IN VIROLOGY, 1994, 145 (3-4): : 163 - 170
  • [37] Correction: Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
    Carolina Q. Sacramento
    Gabrielle R. de Melo
    Caroline S. de Freitas
    Natasha Rocha
    Lucas Villas Bôas Hoelz
    Milene Miranda
    Natalia Fintelman-Rodrigues
    Andressa Marttorelli
    André C. Ferreira
    Giselle Barbosa-Lima
    Juliana L. Abrantes
    Yasmine Rangel Vieira
    Mônica M. Bastos
    Eduardo de Mello Volotão
    Estevão Portela Nunes
    Diogo A. Tschoeke
    Luciana Leomil
    Erick Correia Loiola
    Pablo Trindade
    Stevens K. Rehen
    Fernando A. Bozza
    Patrícia T. Bozza
    Nubia Boechat
    Fabiano L. Thompson
    Ana M. B. de Filippis
    Karin Brüning
    Thiago Moreno L. Souza
    Scientific Reports, 7
  • [38] HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages
    Nowak, P
    Barqasho, B
    Treutiger, CJ
    Harris, HE
    Tracey, KJ
    Andersson, J
    Sönnerborg, A
    CYTOKINE, 2006, 34 (1-2) : 17 - 23
  • [39] HIV-1 Replication and APOBEC3 Antiviral Activity Are Not Regulated by P Bodies
    Phalora, Prabhjeet K.
    Sherer, Nathan M.
    Wolinsky, Steven M.
    Swanson, Chad M.
    Malim, Michael H.
    JOURNAL OF VIROLOGY, 2012, 86 (21) : 11712 - 11724
  • [40] New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo
    McMahon, Moira A.
    Shen, Lin
    Siliciano, Robert F.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (06) : 574 - 582
12345